Citation:Ahmed KA, Abuodeh YA, Echevarria MI, Arrington JA, Stallworth DG, Hogue C, et al 2016

Citation

Ahmed KA, Abuodeh YA, Echevarria MI, Arrington JA, Stallworth DG, Hogue C, et al. Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy. Ann Oncol 2016 Dec;27(12):2288-2294 Available from: http://www.ncbi.nlm.nih.gov/pubmed/27637745.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Ahmed KA, Abuodeh YA, Echevarria MI, Arrington JA, Stallworth DG, Hogue C, et al 2016	For patients with distant metastases (other than brain metastases), when is radiotherapy indicated?	Cecilia Taing	completed
Ahmed KA, Abuodeh YA, Echevarria MI, Arrington JA, Stallworth DG, Hogue C, et al 2016 2	For patients with distant metastases (other than brain metastases), when is radiotherapy indicated?	Tamsin Parrish	completed

Compare quality appraisals for each clinical question

• [[Clinical question:When is radiotherapy indicated for melanoma patients with distant metastasis?|]] (compare critical appraisals)
• [[Clinical question:When is radiotherapy indicated for melanoma patients with distant metastasis?|]] (compare critical appraisals)

Cited by

1. For patients with distant metastases (other than brain metastases), when is radiotherapy indicated?
2. Radiotherapy in the management of advanced melanoma patient with brain metastases